The Imperative for Diversity and Inclusion in Clinical Trials and Health Research Participation
JAMA
.
2022 Jun 21;327(23):2283-2284.
doi: 10.1001/jama.2022.9083.
Authors
Kirsten Bibbins-Domingo
1
,
Alex Helman
2
,
Victor J Dzau
3
Affiliations
1
Department of Epidemiology and Biostatistics, University of California, San Francisco.
2
National Academies of Sciences, Engineering, and Medicine, Washington, DC.
3
National Academy of Medicine, Washington, DC.
PMID:
35579885
DOI:
10.1001/jama.2022.9083
No abstract available
MeSH terms
Biomedical Research* / standards
Clinical Trials as Topic* / standards
Cultural Diversity*
Patient Selection*
Prejudice*
Social Inclusion*